These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

659 related articles for article (PubMed ID: 25623524)

  • 1. Familial focal epilepsy with focal cortical dysplasia due to DEPDC5 mutations.
    Baulac S; Ishida S; Marsan E; Miquel C; Biraben A; Nguyen DK; Nordli D; Cossette P; Nguyen S; Lambrecq V; Vlaicu M; Daniau M; Bielle F; Andermann E; Andermann F; Leguern E; Chassoux F; Picard F
    Ann Neurol; 2015 Apr; 77(4):675-83. PubMed ID: 25623524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Second-hit mosaic mutation in mTORC1 repressor DEPDC5 causes focal cortical dysplasia-associated epilepsy.
    Ribierre T; Deleuze C; Bacq A; Baldassari S; Marsan E; Chipaux M; Muraca G; Roussel D; Navarro V; Leguern E; Miles R; Baulac S
    J Clin Invest; 2018 Jun; 128(6):2452-2458. PubMed ID: 29708508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in mammalian target of rapamycin regulator DEPDC5 cause focal epilepsy with brain malformations.
    Scheffer IE; Heron SE; Regan BM; Mandelstam S; Crompton DE; Hodgson BL; Licchetta L; Provini F; Bisulli F; Vadlamudi L; Gecz J; Connelly A; Tinuper P; Ricos MG; Berkovic SF; Dibbens LM
    Ann Neurol; 2014 May; 75(5):782-7. PubMed ID: 24585383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of GATOR complex genes in familial focal epilepsies and focal cortical dysplasia.
    Weckhuysen S; Marsan E; Lambrecq V; Marchal C; Morin-Brureau M; An-Gourfinkel I; Baulac M; Fohlen M; Kallay Zetchi C; Seeck M; de la Grange P; Dermaut B; Meurs A; Thomas P; Chassoux F; Leguern E; Picard F; Baulac S
    Epilepsia; 2016 Jun; 57(6):994-1003. PubMed ID: 27173016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comprehensive clinico-pathological and genetic evaluation of bottom-of-sulcus focal cortical dysplasia in patients with difficult-to-localize focal epilepsy.
    Ying Z; Wang I; Blümcke I; Bulacio J; Alexopoulos A; Jehi L; Bingaman W; Gonzalez-Martinez J; Kobow K; Niestroj LM; Lal D; Koelble K; Najm I
    Epileptic Disord; 2019 Feb; 21(1):65-77. PubMed ID: 30782578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A recurrent mutation in DEPDC5 predisposes to focal epilepsies in the French-Canadian population.
    Martin C; Meloche C; Rioux MF; Nguyen DK; Carmant L; Andermann E; Gravel M; Cossette P
    Clin Genet; 2014 Dec; 86(6):570-4. PubMed ID: 24283814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DEPDC5 mutations in familial and sporadic focal epilepsy.
    Tsai MH; Chan CK; Chang YC; Yu YT; Chuang ST; Fan WL; Li SC; Fu TY; Chang WN; Liou CW; Chuang YC; Ng CC; Hwang DY; Lim KS
    Clin Genet; 2017 Oct; 92(4):397-404. PubMed ID: 28170089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mammalian target of rapamycin pathway mutations cause hemimegalencephaly and focal cortical dysplasia.
    D'Gama AM; Geng Y; Couto JA; Martin B; Boyle EA; LaCoursiere CM; Hossain A; Hatem NE; Barry BJ; Kwiatkowski DJ; Vinters HV; Barkovich AJ; Shendure J; Mathern GW; Walsh CA; Poduri A
    Ann Neurol; 2015 Apr; 77(4):720-5. PubMed ID: 25599672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetics advances in autosomal dominant focal epilepsies: focus on DEPDC5.
    Baulac S
    Prog Brain Res; 2014; 213():123-39. PubMed ID: 25194487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in DEPDC5 cause familial focal epilepsy with variable foci.
    Dibbens LM; de Vries B; Donatello S; Heron SE; Hodgson BL; Chintawar S; Crompton DE; Hughes JN; Bellows ST; Klein KM; Callenbach PM; Corbett MA; Gardner AE; Kivity S; Iona X; Regan BM; Weller CM; Crimmins D; O'Brien TJ; Guerrero-López R; Mulley JC; Dubeau F; Licchetta L; Bisulli F; Cossette P; Thomas PQ; Gecz J; Serratosa J; Brouwer OF; Andermann F; Andermann E; van den Maagdenberg AM; Pandolfo M; Berkovic SF; Scheffer IE
    Nat Genet; 2013 May; 45(5):546-51. PubMed ID: 23542697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epilepsy surgery of focal cortical dysplasia-associated tumors.
    Cossu M; Fuschillo D; Bramerio M; Galli C; Gozzo F; Pelliccia V; Casaceli G; Tassi L; Lo Russo G
    Epilepsia; 2013 Dec; 54 Suppl 9():115-22. PubMed ID: 24328884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DEPDC5 takes a second hit in familial focal epilepsy.
    Anderson MP
    J Clin Invest; 2018 Jun; 128(6):2194-2196. PubMed ID: 29708509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DEPDC5 mutations in families presenting as autosomal dominant nocturnal frontal lobe epilepsy.
    Picard F; Makrythanasis P; Navarro V; Ishida S; de Bellescize J; Ville D; Weckhuysen S; Fosselle E; Suls A; De Jonghe P; Vasselon Raina M; Lesca G; Depienne C; An-Gourfinkel I; Vlaicu M; Baulac M; Mundwiller E; Couarch P; Combi R; Ferini-Strambi L; Gambardella A; Antonarakis SE; Leguern E; Steinlein O; Baulac S
    Neurology; 2014 Jun; 82(23):2101-6. PubMed ID: 24814846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GATOR1-related focal cortical dysplasia in epilepsy surgery patients and their families: A possible gradient in severity?
    Benova B; Sanders MWCB; Uhrova-Meszarosova A; Belohlavkova A; Hermanovska B; Novak V; Stanek D; Vlckova M; Zamecnik J; Aronica E; Braun KPJ; Koeleman BPC; Jansen FE; Krsek P
    Eur J Paediatr Neurol; 2021 Jan; 30():88-96. PubMed ID: 33461085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatic Mutations in the MTOR gene cause focal cortical dysplasia type IIb.
    Nakashima M; Saitsu H; Takei N; Tohyama J; Kato M; Kitaura H; Shiina M; Shirozu H; Masuda H; Watanabe K; Ohba C; Tsurusaki Y; Miyake N; Zheng Y; Sato T; Takebayashi H; Ogata K; Kameyama S; Kakita A; Matsumoto N
    Ann Neurol; 2015 Sep; 78(3):375-86. PubMed ID: 26018084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial cortical dysplasia caused by mutation in the mammalian target of rapamycin regulator NPRL3.
    Sim JC; Scerri T; Fanjul-Fernández M; Riseley JR; Gillies G; Pope K; van Roozendaal H; Heng JI; Mandelstam SA; McGillivray G; MacGregor D; Kannan L; Maixner W; Harvey AS; Amor DJ; Delatycki MB; Crino PB; Bahlo M; Lockhart PJ; Leventer RJ
    Ann Neurol; 2016 Jan; 79(1):132-7. PubMed ID: 26285051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissecting the genetic basis of focal cortical dysplasia: a large cohort study.
    Baldassari S; Ribierre T; Marsan E; Adle-Biassette H; Ferrand-Sorbets S; Bulteau C; Dorison N; Fohlen M; Polivka M; Weckhuysen S; Dorfmüller G; Chipaux M; Baulac S
    Acta Neuropathol; 2019 Dec; 138(6):885-900. PubMed ID: 31444548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pearls & Oy-sters: Harnessing New Diagnostic and Therapeutic Approaches to Treat a Patient With Genetic Drug-Resistant Focal Epilepsy.
    Khan A; Middlebrooks EH; Javarayee P; Tatum WO; Sanchez Bolurate SS; Grewal SS; Feyissa AM
    Neurology; 2023 May; 100(21):1020-1024. PubMed ID: 36697241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A stereo EEG study in a patient with sleep-related hypermotor epilepsy due to DEPDC5 mutation.
    Ferri L; Bisulli F; Mai R; Licchetta L; Leta C; Nobili L; Mostacci B; Pippucci T; Tinuper P
    Seizure; 2017 Dec; 53():51-54. PubMed ID: 29125946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in the mammalian target of rapamycin pathway regulators NPRL2 and NPRL3 cause focal epilepsy.
    Ricos MG; Hodgson BL; Pippucci T; Saidin A; Ong YS; Heron SE; Licchetta L; Bisulli F; Bayly MA; Hughes J; Baldassari S; Palombo F; ; Santucci M; Meletti S; Berkovic SF; Rubboli G; Thomas PQ; Scheffer IE; Tinuper P; Geoghegan J; Schreiber AW; Dibbens LM
    Ann Neurol; 2016 Jan; 79(1):120-31. PubMed ID: 26505888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.